Akute Gastroenteritis im Kindes- und Erwachsenenalter

Die häufigste Ursache für eine infektiöse Diarrhö sind virale Infektionen. Bei einer Diarrhö gilt es jedoch stets, zahlreiche Aspekte – wie Dauer der Diarrhö, ambulant oder nosokomial erworben, Alter des Patienten – zu beachten. In diesem Beitrag werden epidemiologische Daten, Diagnostik, Therapie und eine Diskussion der wichtigsten Erreger der infektiösen Diarrhö bei Kindern und Erwachsenen dargestellt.

Schlüsselwörter

Diarrhö - Norovirus - Campylobacter - orale Rehydration - Clostridioides difficile

• Literatur

• 1 Guarino A, Ashkenazi S, Gendrel D. et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr 2014; 59: 132-152
• 2 Wilking H, Spitznagel H, Werber D. et al. Acute gastrointestinal illness in adults in Germany: a population-based telephone survey. Epidemiol Infect 2013; 141: 2365-2375
• 3 Schlinkmann KM, Bakuli A, Karch A. et al. Transmission of respiratory and gastrointestinal infections in German households with children attending child care. Epidemiol Infect 2018; 146: 627-632
• 4 Robert Koch Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2018. Im Internet (Stand: 01.10.2020): http://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2018.pdf?__blob=publicationFile
• 5 Aliabadi N, Tate JE, Haynes AK. et al. Centers for Disease Control and Prevention (CDC). Sustained decrease in laboratory detection of rotavirus after implementation of routine vaccination-United States, 2000–2014. MMWR Morb Mortal Wkly Rep 2015; 64: 337-342
• 6 Wiegering V, Kaiser J, Tappe D. et al. Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients. Int J Infect Dis 2011; 15: e401-e407
• 7 Lübbert C. Steigende Hospitalisierungs und Mortalitätsraten. Dtsch Ärztebl (Suppl. Perspektiven der Infektiologie & Immunologie 1/2019). Im Internet (Stand 01.10.2020): http://cdn.aerzteblatt.de/pdf/116/29/p24.pdf?ts=16%252E07%252E2019+19%253A09%253A31
• 8 Lynen Jansen P, Stallmach A, Lohse AW. et al. [Development of gastrointestinal infectious diseases between 2000 and 2012]. Z Gastroenterol 2014; 52: 549-557
• 9 Hagel S, Epple HJ, Feurle GE. et al. [S2k-guideline gastrointestinal infectious diseases and Whippleʼs disease]. Z Gastroenterol 2015; 53: 418-459
• 10 Le Guern R, Loiez C, Grandbastien B. et al. Performance of stool cultures before and after a 3-day hospitalization: fewer cultures, better for patients and for money. Diagn Microbiol Infect Dis 2013; 77: 5-7
• 11 Manthey CF, Dranova D, Christner M. et al. Stool cultures at the ICU: get rid of it!. Ann Intensive Care 2018; 8: 10
• 12 Valenstein P, Pfaller M, Yungbluth M. The use and abuse of routine stool microbiology: a College of American Pathologists Q-probes study of 601 institutions. Arch Pathol Lab Med 1996; 120: 206-211
• 13 Deshpande A, Pasupuleti V, Patel P. et al. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield. Clin Gastroenterol Hepatol 2011; 9: 665-669.e1
• 14 Lubbert C, Mutters R. [Gastrointestinal infections]. Internist 2017; 58: 149-169
• 15 Lübbert C, Vogelmann R. Hrsg. Gastroenterologische Infektiologie. Berlin: De Gruyter; 2017
• 16 Backendorf V, Buderus S, Claßen M. et al. S2k-Leitlinie akute infektiöse Gastroenteritis im Säuglings-, Kindes- und Jugendalter. März 2019. AWMF Registernummer 068-003. Im Internet (Stand: 01.10.2020): http://www.awmf.org/leitlinien/detail/ll/068-003.html
• 17 National Collaborating Centre for Womenʼs and Childrenʼs Health (UK). Diarrhöa and Vomiting caused by Gastroenteritis Diagnosis, Assessment and Management in Children younger than 5 Years. London: RCOG Press; 2009
• 18 Thielman NM, Guerrant RL. Clinical practice. Acute infectious diarrhea. N Engl J Med 2004; 350: 38-47
• 19 Su GL, Ko CW, Bercik P. et al. AGA Clinical Practice Guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology 2020; 159: 697-705
• 20 Hempel S, Newberry SJ, Maher AR. et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307: 1959-1969
• 21 Steffen R, Hill DR, DuPont HL. Travelerʼs diarrhea: a clinical review. JAMA 2015; 313: 71-80
• 22 Dalby-Payne JR, Elliott EJ. Gastroenteritis in children. BMJ Clin Evid 2011; 2011: 0314
• 23 Patel MM, Widdowson MA, Glass RI. et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008; 14: 1224-1231
• 24 Bok K, Prevots DR, Binder AM. et al. Epidemiology of norovirus infection among immunocompromised patients at a tertiary care research hospital, 2010–2013. Open Forum Infect Dis 2016; 3: ofw169
• 25 Crawford SE, Ramani S, Tate JE. et al. Rotavirus infection. Nat Rev Dis Primers 2017; 3: 17083
• 26 Heim A, Dürrwald R. Infektionen mit humanen Adenoviren. Epid Bull 2019; 22: 187-189 doi:10.25646/6158
• 27 Sproston EL, Wimalarathna HML, Sheppard SK. Trends in fluoroquinolone resistance in Campylobacter. Microb Genom 2018; 4: e000198
• 28 Onwuezobe IA, Oshun PO, Odigwe CC. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev 2012; (11): CD001167. Cochrane Database Syst Rev 2012; (11) CD001167
• 29 McCrickard LS, Crim SM, Kim S. et al. Disparities in severe shigellosis among adults – Foodborne diseases active surveillance network, 2002–2014. BMC Public Health 2018; 18: 221
• 30 Press N, Fyfe M, Bowie W. et al. Clinical and microbiological follow-up of an outbreak of Yersinia pseudotuberculosis serotype Ib. Scand J Infect Dis 2001; 33: 523-526
• 31 Bielaszewska M, Mellmann A, Zhang W. et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 2011; 11: 671-676
• 32 Bauer A, Loos S, Wehrmann C. et al. Neurological involvement in children with E. coli O104: H4-induced hemolytic uremic syndrome. Pediatr Nephrol 2014; 29: 1607-1615
• 33 Menne J, Nitschke M, Stingele R. et al. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104: H4 induced haemolytic uraemic syndrome: case-control study. BMJ 2012; 345: e4565
• 34 Manthey CF, Eckmann L, Fuhrmann V. Therapy for Clostridium difficile infection – any news beyond Metronidazole and Vancomycin?. Expert Rev Clin Pharmacol 2017; 10: 1239-1250
• 35 Weichert S, Simon A, von Müller L. et al. Clostridium-difficile-assoziierte Infektionen im Kindes- und Jugendalter. Monatsschrift Kinderheilkunde 2015; 163: 427-436
• 36 Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med 2015; 372: 1539-1548
• 37 Hung YP, Lee JC, Lin HJ. et al. Clinical impact of Clostridium difficile colonization. J Microbiol Immunol Infect 2015; 48: 241-248
• 38 Dylewski J. The value of repeat Clostridium difficile toxin testing during and after an outbreak of C difficile-associated diarrhea. Can J Infect Dis Med Microbiol 2011; 22: e12-15
• 39 Crobach MJ, Dekkers OM, Wilcox MH. et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009; 15: 1053-1066
• 40 Louie TJ, Miller MA, Mullane KM. et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011; 364: 422-431
• 41 Rokas KE, Johnson JW, Beardsley JR. et al. The addition of intravenous metronidazole to oral vancomycin is associated with improved mortality in critically ill patients with Clostridium difficile infection. Clin Infect Dis 2015; 61: 934-941
• 42 Lübbert C, Lippmann N, von Braun A. Neue Leitlinien und Daten zu Clostridium difficile – Was ändert sich?. Dtsch Med Wochenschr 2018; 143: 787-792
• 43 McDonald LC, Gerding DN, Johnson S. et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018; 66: 987-994
• 44 Wilcox MH, Gerding DN, Poxton IR. et al. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Engl J Med 2017; 376: 305-317
• 45 van Nood E, Vrieze A, Nieuwdorp M. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-415
• 46 Youngster I, Russell GH, Pindar C. et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014; 312: 1772-1778
• 47 Zagorowicz E, Bugajski M, Wieszczy P. et al. Cytomegalovirus infection in ulcerative colitis is related to severe inflammation and a high count of cytomegalovirus-positive cells in biopsy is a risk factor for colectomy. J Crohns Colitis 2016; 10: 1205-1211
• 48 Okahara K, Nagata N, Shimada T. et al. Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis. PloS One 2017; 12: e0183951
• 49 Kucharzik T, Maaser C. Infections and chronic inflammatory bowel disease. Viszeralmedizin 2014; 30: 326-332
• 50 Boggild AK, Geduld J, Libman M. et al. Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009–2011. Open Med 2014; 8: e20-e32
• 51 Andresen V, Löwe B, Broicher W. et al. Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104: H4: A cohort study with prospective follow-up. United European Gastroenterol J 2016; 4: 121-131
• 52 Torbicki E, Oh J, Mishra S. et al. Interventions for post-infectious irritable bowel syndrome: a systematic review of treatment efficacy. Trop Dis Travel Med Vaccines 2015; 1: 1
• 53 Thabane M, Simunovic M, Akhtar-Danesh N. et al. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol 2010; 105: 933-939